Keyphrases
Matrix Metalloproteinases
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Skeletal muscle
100%
Exercise-induced
100%
Messenger RNA (mRNA)
50%
Diabetes
33%
Complication Prevention
16%
Diabetes Complications
16%
Vascular Remodeling
16%
Healthy Controls
16%
Physical Training
16%
Tissue Inhibitors
16%
Response to Training
16%
Protein Response
16%
Uncontrolled Type 2 Diabetes
16%
Active Matrix
16%
Control Subjects
16%
Matrix metalloproteinase-2 (MMP-2)
16%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Matrix Metalloproteinase
100%
Skeletal Muscle
100%
Type 2 Diabetes
66%
Messenger RNA
50%
Diabetes
50%
Metalloprotease Inhibitor
33%
Gelatinase A
16%
Vascular Remodeling
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Matrix Metalloproteinase
100%
Non Insulin Dependent Diabetes Mellitus
100%
Messenger RNA
50%
Tissue Inhibitor of Metalloproteinase
33%
Vascular Remodeling
16%
Diseases
16%
Gelatinase A
16%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Matrix Metalloproteinase
100%
Messenger RNA
50%
Tissue Inhibitor of Metalloproteinase
33%
Diseases
16%
Vascular Remodeling
16%
Gelatinase A
16%
Neuroscience
Matrix Metalloproteinase
100%
Skeletal Muscle
100%
Messenger RNA
50%
Metalloprotease Inhibitor
33%
MMP2
16%
Immunology and Microbiology